De to andre undersøgelser viste, at alle pigerne i alderen 10- 14 år, som fik Cervarix, udviklede beskyttende niveauer af antistoffer mod HPV- type 16 og 18.
The additional studies showed that all of the girls aged 10 to 14 years who were given Cervarix developed protective levels of antibodies against HPV types 16 and 18.